Home › Companies › CORCEPT THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and CORCEPT THERAPEUTICS INC.’s Form 8-K, filed 2024-05-23 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore CORCEPT THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are CORCEPT THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-23 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Gregg Alton | 60,315,939 | -- | -- | 5,562,189 | 22,496,236 | Majority: yes |
| Elect Director: G. Leonard Baker, Jr. | 62,443,392 | -- | -- | 3,434,736 | 22,496,236 | Majority: yes |
| Elect Director: Joseph K. Belanoff, M.D. | 65,590,721 | -- | -- | 287,407 | 22,496,236 | Majority: yes |
| Elect Director: Gillian M. Cannon, Ph.D. | 63,808,757 | -- | -- | 2,004,740 | 22,560,867 | Majority: yes |
| Elect Director: David L. Mahoney | 64,919,195 | -- | -- | 958,933 | 22,496,236 | Majority: yes |
| Elect Director: Joshua M. Murray | 65,624,110 | -- | -- | 254,018 | 22,496,236 | Majority: yes |
| Elect Director: Kimberly Park | 56,969,410 | -- | -- | 8,908,718 | 22,496,236 | Majority: yes |
| Elect Director: Daniel N. Swisher, Jr. | 65,622,142 | -- | -- | 255,986 | 22,496,236 | Majority: yes |
| Elect Director: James N. Wilson | 62,619,695 | -- | -- | 3,258,433 | 22,496,236 | Majority: yes |
| Proposal 2 - The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified. | 86,596,528 | 1,707,066 | 70,770 | -- | -- | Majority: yes |
| Proposal 3 - The compensation of named executive officers was approved, on an advisory basis. | 64,501,372 | 1,018,089 | 358,666 | -- | 22,496,237 | Majority: yes |
| Proposal 4 - The Corcept Therapeutics Incorporated 2024 Incentive Award Plan was approved. | 47,018,093 | 18,698,799 | 161,233 | -- | 22,496,239 | Majority: yes |
Source: CORCEPT THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-05-23 — read the filing on EDGAR.
Each item below shows how the 301 asset managers that disclosed a CORCEPT THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CORCEPT THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 12 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Proposal 3 - The compensation of named executive officers was approved, on an advisory basis.”): 64,501,372 for, 1,018,089 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 62% for, 1.0% against (63% of the company cast a for/against vote).
The 299 asset managers below cast 98% of the shares they voted on this item FOR (60,031,901 for, 1,010,735 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Man Group plc | 10,751,900 | 0 | 0 | 0 | For |
| Vanguard | 9,631,253 | 0 | 0 | 0 | For |
| BlackRock | 9,163,987 | 987 | 0 | 0 | For |
| State Street | 4,731,582 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 2,411,362 | 0 | 0 | 0 | For |
| Charles Schwab | 1,838,358 | 0 | 0 | 0 | For |
| First Trust | 1,841,820 | 0 | 0 | 0 | For |
| Dimensional | 1,806,954 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Boston Trust Walden Co | 762,717 | 0 | 0 | 0 | For |
| Fidelity | 751,563 | 0 | 0 | 0 | For |
| Renaissance | 726,046 | 0 | 0 | 0 | For |
| Northern Trust | 656,918 | 55 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 623,025 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 586,192 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 526,344 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 525,267 | 0 | 0 | 0 | For |
| Two Sigma | 478,185 | 0 | 0 | 0 | For |
| Cyrus J. Lawrence, LLC | 460,000 | 0 | 0 | 0 | For |
| Legg Mason | 417,236 | 0 | 0 | 0 | For |
| Cerity Partners LLC | 396,941 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 338,285 | 2,123 | 0 | 0 | For |
| Royce | 336,272 | 0 | 0 | 0 | For |
| BNY Mellon | 310,144 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 294,098 | 0 | 0 | 0 | For |
Showing the 25 largest of 299 asset managers. See all 299 in the interactive database.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Proposal 2 - The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified.”): 86,596,528 for, 1,707,066 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 84% for, 2% against (85% of the company cast a for/against vote).
The 94 asset managers below cast 99.9% of the shares they voted on this item FOR (27,804,028 for, 13,749 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,390,914 | 0 | 0 | 0 | For |
| BlackRock | 6,720,489 | 0 | 0 | 0 | For |
| First Trust | 1,830,396 | 0 | 0 | 0 | For |
| Dimensional | 1,618,776 | 0 | 0 | 0 | For |
| State Street | 1,555,018 | 1,176 | 0 | 0 | For |
| Charles Schwab | 898,696 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Fidelity | 662,010 | 0 | 0 | 0 | For |
| Legg Mason | 417,236 | 0 | 0 | 0 | For |
| Royce | 331,800 | 0 | 0 | 0 | For |
| Jackson National | 282,371 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 246,005 | 0 | 0 | 0 | For |
| Equitable | 219,977 | 0 | 0 | 0 | For |
| TIAA | 215,614 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 202,124 | 0 | 0 | 0 | For |
| ETF Series Solutions | 166,277 | 12,023 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 151,815 | 0 | 0 | 0 | For |
| American Century | 143,440 | 0 | 0 | 0 | For |
| BNY Mellon | 137,568 | 0 | 0 | 0 | For |
| MoA Funds Corp | 133,329 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,556 | 0 | 0 | 0 | For |
| Principal | 104,314 | 0 | 0 | 0 | For |
| AllianceBernstein | 98,204 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 93,600 | 0 | 0 | 0 | For |
| Thrivent | 77,912 | 0 | 0 | 0 | For |
Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: David L. Mahoney”): 64,919,195 for, 958,933 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 63% for, 1.0% withheld (64% of the company cast a for/withheld vote).
The 91 asset managers below cast 100% of the shares they voted on this item FOR (27,774,998 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,390,914 | 0 | 0 | 0 | For |
| BlackRock | 6,720,489 | 0 | 0 | 0 | For |
| First Trust | 1,830,396 | 0 | 0 | 0 | For |
| Dimensional | 1,618,776 | 0 | 0 | 0 | For |
| State Street | 1,552,703 | 0 | 3,491 | 0 | For |
| Charles Schwab | 898,696 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Fidelity | 662,010 | 0 | 0 | 0 | For |
| Legg Mason | 417,236 | 0 | 0 | 0 | For |
| Royce | 331,800 | 0 | 0 | 0 | For |
| Jackson National | 282,371 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 246,005 | 0 | 0 | 0 | For |
| Equitable | 219,977 | 0 | 0 | 0 | For |
| TIAA | 215,614 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 202,124 | 0 | 0 | 0 | For |
| ETF Series Solutions | 166,277 | 0 | 12,023 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 151,815 | 0 | 0 | 0 | For |
| American Century | 143,440 | 0 | 0 | 0 | For |
| BNY Mellon | 137,568 | 0 | 0 | 0 | For |
| MoA Funds Corp | 133,329 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,556 | 0 | 0 | 0 | For |
| Principal | 104,314 | 0 | 0 | 0 | For |
| AllianceBernstein | 98,204 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 93,600 | 0 | 0 | 0 | For |
| Thrivent | 77,912 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: G. Leonard Baker, Jr.”): 62,443,392 for, 3,434,736 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 60% for, 3% withheld (64% of the company cast a for/withheld vote).
The 91 asset managers below cast 100% of the shares they voted on this item FOR (27,349,835 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,390,914 | 0 | 0 | 0 | For |
| BlackRock | 6,720,489 | 0 | 0 | 0 | For |
| First Trust | 1,830,396 | 0 | 0 | 0 | For |
| Dimensional | 1,618,776 | 0 | 0 | 0 | For |
| State Street | 1,551,134 | 0 | 5,060 | 0 | For |
| Charles Schwab | 898,696 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Fidelity | 662,010 | 0 | 0 | 0 | For |
| Legg Mason | 417,236 | 0 | 0 | 0 | For |
| Royce | 331,800 | 0 | 0 | 0 | For |
| Jackson National | 282,371 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 246,005 | 0 | Abstain |
| Equitable | 219,977 | 0 | 0 | 0 | For |
| TIAA | 215,614 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 202,124 | 0 | 0 | 0 | For |
| ETF Series Solutions | 166,277 | 0 | 12,023 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 151,815 | 0 | 0 | 0 | For |
| American Century | 143,440 | 0 | 0 | 0 | For |
| BNY Mellon | 137,568 | 0 | 0 | 0 | For |
| MoA Funds Corp | 133,329 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,556 | 0 | 0 | 0 | For |
| Principal | 104,314 | 0 | 0 | 0 | For |
| AllianceBernstein | 98,204 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 93,600 | 0 | 0 | 0 | For |
| Thrivent | 77,912 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gillian M. Cannon, Ph.D.”): 63,808,757 for, 2,004,740 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 62% for, 2% withheld (64% of the company cast a for/withheld vote).
The 91 asset managers below cast 100% of the shares they voted on this item FOR (27,777,811 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,390,914 | 0 | 0 | 0 | For |
| BlackRock | 6,720,489 | 0 | 0 | 0 | For |
| First Trust | 1,830,396 | 0 | 0 | 0 | For |
| Dimensional | 1,618,776 | 0 | 0 | 0 | For |
| State Street | 1,552,310 | 0 | 3,884 | 0 | For |
| Charles Schwab | 898,696 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Fidelity | 662,010 | 0 | 0 | 0 | For |
| Legg Mason | 417,236 | 0 | 0 | 0 | For |
| Royce | 331,800 | 0 | 0 | 0 | For |
| Jackson National | 282,371 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 246,005 | 0 | 0 | 0 | For |
| Equitable | 219,977 | 0 | 0 | 0 | For |
| TIAA | 215,614 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 202,124 | 0 | 0 | 0 | For |
| ETF Series Solutions | 178,300 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 151,815 | 0 | 0 | 0 | For |
| American Century | 143,440 | 0 | 0 | 0 | For |
| BNY Mellon | 137,568 | 0 | 0 | 0 | For |
| MoA Funds Corp | 133,329 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,556 | 0 | 0 | 0 | For |
| Principal | 104,314 | 0 | 0 | 0 | For |
| AllianceBernstein | 98,204 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 93,600 | 0 | 0 | 0 | For |
| Thrivent | 77,912 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 3 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gregg Alton”): 60,315,939 for, 5,562,189 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 58% for, 5% withheld (64% of the company cast a for/withheld vote).
The 91 asset managers below cast 100% of the shares they voted on this item FOR (24,497,541 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,390,914 | 0 | 0 | 0 | For |
| BlackRock | 6,720,489 | 0 | 0 | 0 | For |
| First Trust | 1,830,396 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 1,618,776 | 0 | Abstain |
| State Street | 25,394 | 0 | 1,530,800 | 0 | Abstain |
| Charles Schwab | 898,696 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Fidelity | 662,010 | 0 | 0 | 0 | For |
| Legg Mason | 417,236 | 0 | 0 | 0 | For |
| Royce | 331,800 | 0 | 0 | 0 | For |
| Jackson National | 259,429 | 0 | 22,942 | 0 | For |
| Columbia Threadneedle | 246,005 | 0 | 0 | 0 | For |
| Equitable | 219,977 | 0 | 0 | 0 | For |
| TIAA | 215,614 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 202,124 | 0 | 0 | 0 | For |
| ETF Series Solutions | 178,300 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 151,815 | 0 | 0 | 0 | For |
| American Century | 143,440 | 0 | 0 | 0 | For |
| BNY Mellon | 137,568 | 0 | 0 | 0 | For |
| MoA Funds Corp | 133,329 | 0 | 0 | 0 | For |
| Lincoln Financial | 36,283 | 0 | 77,273 | 0 | Abstain |
| Principal | 104,079 | 0 | 235 | 0 | For |
| AllianceBernstein | 98,204 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 93,600 | 0 | 0 | 0 | For |
| Thrivent | 77,912 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: James N. Wilson”): 62,619,695 for, 3,258,433 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 61% for, 3% withheld (64% of the company cast a for/withheld vote).
The 91 asset managers below cast 100% of the shares they voted on this item FOR (27,349,835 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,390,914 | 0 | 0 | 0 | For |
| BlackRock | 6,720,489 | 0 | 0 | 0 | For |
| First Trust | 1,830,396 | 0 | 0 | 0 | For |
| Dimensional | 1,618,776 | 0 | 0 | 0 | For |
| State Street | 1,551,134 | 0 | 5,060 | 0 | For |
| Charles Schwab | 898,696 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Fidelity | 662,010 | 0 | 0 | 0 | For |
| Legg Mason | 417,236 | 0 | 0 | 0 | For |
| Royce | 331,800 | 0 | 0 | 0 | For |
| Jackson National | 282,371 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 246,005 | 0 | Abstain |
| Equitable | 219,977 | 0 | 0 | 0 | For |
| TIAA | 215,614 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 202,124 | 0 | 0 | 0 | For |
| ETF Series Solutions | 166,277 | 0 | 12,023 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 151,815 | 0 | 0 | 0 | For |
| American Century | 143,440 | 0 | 0 | 0 | For |
| BNY Mellon | 137,568 | 0 | 0 | 0 | For |
| MoA Funds Corp | 133,329 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,556 | 0 | 0 | 0 | For |
| Principal | 104,314 | 0 | 0 | 0 | For |
| AllianceBernstein | 98,204 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 93,600 | 0 | 0 | 0 | For |
| Thrivent | 77,912 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joseph K. Belanoff, M.D.”): 65,590,721 for, 287,407 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 63% for, 0.3% withheld (64% of the company cast a for/withheld vote).
The 91 asset managers below cast 100% of the shares they voted on this item FOR (27,806,378 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,390,914 | 0 | 0 | 0 | For |
| BlackRock | 6,720,489 | 0 | 0 | 0 | For |
| First Trust | 1,830,396 | 0 | 0 | 0 | For |
| Dimensional | 1,618,776 | 0 | 0 | 0 | For |
| State Street | 1,553,560 | 0 | 2,634 | 0 | For |
| Charles Schwab | 898,696 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Fidelity | 662,010 | 0 | 0 | 0 | For |
| Legg Mason | 417,236 | 0 | 0 | 0 | For |
| Royce | 331,800 | 0 | 0 | 0 | For |
| Jackson National | 282,371 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 246,005 | 0 | 0 | 0 | For |
| Equitable | 219,977 | 0 | 0 | 0 | For |
| TIAA | 215,614 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 202,124 | 0 | 0 | 0 | For |
| ETF Series Solutions | 178,300 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 151,815 | 0 | 0 | 0 | For |
| American Century | 143,440 | 0 | 0 | 0 | For |
| BNY Mellon | 137,568 | 0 | 0 | 0 | For |
| MoA Funds Corp | 133,329 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,556 | 0 | 0 | 0 | For |
| Principal | 104,314 | 0 | 0 | 0 | For |
| AllianceBernstein | 98,204 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 93,600 | 0 | 0 | 0 | For |
| Thrivent | 77,912 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joshua M. Murray”): 65,624,110 for, 254,018 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 63% for, 0.3% withheld (64% of the company cast a for/withheld vote).
The 91 asset managers below cast 100% of the shares they voted on this item FOR (27,792,792 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,390,914 | 0 | 0 | 0 | For |
| BlackRock | 6,720,489 | 0 | 0 | 0 | For |
| First Trust | 1,830,396 | 0 | 0 | 0 | For |
| Dimensional | 1,618,776 | 0 | 0 | 0 | For |
| State Street | 1,553,879 | 0 | 2,315 | 0 | For |
| Charles Schwab | 898,696 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Fidelity | 662,010 | 0 | 0 | 0 | For |
| Legg Mason | 417,236 | 0 | 0 | 0 | For |
| Royce | 331,800 | 0 | 0 | 0 | For |
| Jackson National | 282,371 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 246,005 | 0 | 0 | 0 | For |
| Equitable | 219,977 | 0 | 0 | 0 | For |
| TIAA | 215,614 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 202,124 | 0 | 0 | 0 | For |
| ETF Series Solutions | 178,300 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 151,815 | 0 | 0 | 0 | For |
| American Century | 143,440 | 0 | 0 | 0 | For |
| BNY Mellon | 137,568 | 0 | 0 | 0 | For |
| MoA Funds Corp | 133,329 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,556 | 0 | 0 | 0 | For |
| Principal | 104,314 | 0 | 0 | 0 | For |
| AllianceBernstein | 98,204 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 93,600 | 0 | 0 | 0 | For |
| Thrivent | 77,912 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 3 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kimberly Park”): 56,969,410 for, 8,908,718 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 55% for, 9% withheld (64% of the company cast a for/withheld vote).
The 91 asset managers below cast 100% of the shares they voted on this item FOR (24,058,993 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,390,914 | 0 | 0 | 0 | For |
| BlackRock | 6,720,489 | 0 | 0 | 0 | For |
| First Trust | 1,830,396 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 1,618,776 | 0 | Abstain |
| State Street | 23,825 | 0 | 1,532,369 | 0 | Abstain |
| Charles Schwab | 898,696 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Fidelity | 662,010 | 0 | 0 | 0 | For |
| Legg Mason | 417,236 | 0 | 0 | 0 | For |
| Royce | 331,800 | 0 | 0 | 0 | For |
| Jackson National | 259,429 | 0 | 22,942 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 246,005 | 0 | Abstain |
| Equitable | 219,977 | 0 | 0 | 0 | For |
| TIAA | 215,614 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 202,124 | 0 | 0 | 0 | For |
| ETF Series Solutions | 178,300 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 151,815 | 0 | 0 | 0 | For |
| American Century | 143,440 | 0 | 0 | 0 | For |
| BNY Mellon | 137,568 | 0 | 0 | 0 | For |
| MoA Funds Corp | 133,329 | 0 | 0 | 0 | For |
| Lincoln Financial | 36,283 | 0 | 77,273 | 0 | Abstain |
| Principal | 104,314 | 0 | 0 | 0 | For |
| AllianceBernstein | 98,204 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 93,600 | 0 | 0 | 0 | For |
| Thrivent | 77,912 | 0 | 0 | 0 | For |
Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel N. Swisher, Jr.”): 65,622,142 for, 255,986 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 63% for, 0.3% withheld (64% of the company cast a for/withheld vote).
The 90 asset managers below cast 100% of the shares they voted on this item FOR (27,782,792 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,390,914 | 0 | 0 | 0 | For |
| BlackRock | 6,720,489 | 0 | 0 | 0 | For |
| First Trust | 1,830,396 | 0 | 0 | 0 | For |
| Dimensional | 1,618,776 | 0 | 0 | 0 | For |
| State Street | 1,553,879 | 0 | 2,315 | 0 | For |
| Charles Schwab | 898,696 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Fidelity | 662,010 | 0 | 0 | 0 | For |
| Legg Mason | 417,236 | 0 | 0 | 0 | For |
| Royce | 331,800 | 0 | 0 | 0 | For |
| Jackson National | 282,371 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 246,005 | 0 | 0 | 0 | For |
| Equitable | 219,977 | 0 | 0 | 0 | For |
| TIAA | 215,614 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 202,124 | 0 | 0 | 0 | For |
| ETF Series Solutions | 178,300 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 151,815 | 0 | 0 | 0 | For |
| American Century | 143,440 | 0 | 0 | 0 | For |
| BNY Mellon | 137,568 | 0 | 0 | 0 | For |
| MoA Funds Corp | 133,329 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,556 | 0 | 0 | 0 | For |
| Principal | 104,314 | 0 | 0 | 0 | For |
| AllianceBernstein | 98,204 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 93,600 | 0 | 0 | 0 | For |
| Thrivent | 77,912 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. See all 90 in the interactive database.
Combines 3 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
CORCEPT THERAPEUTICS INC.’s own tally for this item (“Proposal 4 - The Corcept Therapeutics Incorporated 2024 Incentive Award Plan was approved.”): 47,018,093 for, 18,698,799 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,405,000 outstanding shares: 45.5% for, 18% against (64% of the company cast a for/against vote).
The 90 asset managers below cast 69% of the shares they voted on this item FOR (19,082,904 for, 8,683,345 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,323,314 | 67,600 | 0 | 0 | For |
| BlackRock | 6,720,489 | 0 | 0 | 0 | For |
| First Trust | 0 | 1,830,396 | 0 | 0 | Against |
| Dimensional | 0 | 1,618,776 | 0 | 0 | Against |
| State Street | 10,140 | 1,546,054 | 0 | 0 | Against |
| Charles Schwab | 898,696 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 763,075 | 0 | 0 | 0 | For |
| Fidelity | 633,219 | 28,791 | 0 | 0 | For |
| Legg Mason | 0 | 417,236 | 0 | 0 | Against |
| Royce | 0 | 331,800 | 0 | 0 | Against |
| Jackson National | 0 | 282,371 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 246,005 | 0 | 0 | Against |
| Equitable | 125,817 | 94,160 | 0 | 0 | For |
| TIAA | 0 | 215,614 | 0 | 0 | Against |
| Janus Detroit Street Trust | 0 | 202,124 | 0 | 0 | Against |
| ETF Series Solutions | 21,398 | 156,902 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 151,815 | 0 | 0 | 0 | For |
| American Century | 0 | 143,440 | 0 | 0 | Against |
| BNY Mellon | 0 | 137,568 | 0 | 0 | Against |
| MoA Funds Corp | 0 | 133,329 | 0 | 0 | Against |
| Lincoln Financial | 0 | 113,556 | 0 | 0 | Against |
| Principal | 235 | 104,079 | 0 | 0 | Against |
| AllianceBernstein | 0 | 98,204 | 0 | 0 | Against |
| Guardian Variable Products Trust | 0 | 93,600 | 0 | 0 | Against |
| Thrivent | 0 | 77,912 | 0 | 0 | Against |
Showing the 25 largest of 90 asset managers. See all 90 in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 4 asset managers below cast 100% of the shares they voted on this item FOR (21,541 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Jackson Creek Investment Advisors LLC | 14,373 | 0 | 0 | 0 | For |
| TIMOTHY PLAN | 5,531 | 0 | 0 | 0 | For |
| SYNTAX ETF TRUST | 1,487 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 150 | 0 | 0 | 0 | For |
0% fund support · no official result
The 3 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 78,141 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 0 | 70,230 | 0 | 0 | Against |
| TIMOTHY PLAN | 0 | 5,531 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 0 | 2,380 | 0 | 0 | Against |
Ranked by the number of CORCEPT THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 103,405,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Man Group plc | 10.40% |
| 2 | Vanguard | 9.31% |
| 3 | BlackRock | 8.86% |
| 4 | State Street | 4.58% |
| 5 | Novo Holdings A/S | 2.33% |
| 6 | Charles Schwab | 1.81% |
| 7 | First Trust | 1.78% |
| 8 | Dimensional | 1.75% |
| 9 | BOSTON TRUST WALDEN FUNDS | 0.74% |
| 10 | Boston Trust Walden Co | 0.74% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 11.65% | 13F |
| Vanguard Group | 9.22% | 13F |
| Ingalls & Snyder, LLC and affiliated entities | 7.99% | DEF14A |
| Renaissance Technologies | 6.50% | DEF14A |
| Joseph K. Belanoff, M.D. | 6.50% | DEF14A |
| G. Leonard Baker, Jr. | 5.33% | 13G |
| State Street | 3.46% | 13F |
| James N. Wilson | 2.96% | DEF14A |
| Dimensional Fund Advisors | 2.48% | 13F |
| FMR (Fidelity) | 2.13% | 13F |
Percentages above are of 103,405,000 shares outstanding, as reported by CORCEPT THERAPEUTICS INC. on its Form 10-K dated 2023-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CORCEPT THERAPEUTICS INC.’s 10-K dated 2023-12-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At CORCEPT THERAPEUTICS INC.'s shareholder meeting held 2024-05-17, in the 2023-2024 proxy season, 301 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,698 separate fund positions. Their filings are grouped here into 14 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CORCEPT THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-23.
CORCEPT THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.